A smarter route to the brain: Preserving the BBB in preclinical brain tumor models by Evelyn Ma | Oct 23, 2025
Transforming Preclinical Oncology: How Reaction Biology is Revolutionizing Cancer Research by Evelyn Ma | Feb 21, 2025
Functional characterization of a novel somatic oncogenic mutation of PIK3CB. Signal Transduction and Targeted Therapy, 2017 by Reaction Biology | Jul 6, 2023